Back to VA Vanguard Capital Management LLC

JBIO

2 quarters

Position history for VAVanguard Capital Management LLC's holdings in Jade Biosciences, Inc.

Yes. Vanguard Capital Management holds 2,244,773 shares of JBIO (Jade Biosciences), worth $49.9M, as of its Q2 2026 13F filing. It increased the position by 448,121 shares (+24.9%) from Q1 2026. Vanguard Capital Management has held JBIO in every 13F on record since Q1 2026, 2 quarterly filings.

Current Value

$49.9M

Current Shares

2.2M

Total Value Change

+$24.6M

Total Shares Change

+448,121

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.2M
+24.9%
$49.9M0.0%$22.22
36
2026-Q1
First report
1.8M
-
$25.2M0.0%$14.05
0

Other major holders of JBIO: FMR LLC, Jupiter Topco LLC, RA Capital Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used